Healthcare Polish Community
Our community narratives are driven by numbers and valuation.
Healthcare Polish Investing Ideas
Cardiac marker could be a hit
In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.
1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
PH
zł204.19
25.2% overvalued intrinsic discount
Phetuvov Fair Value
Revenue growth
8.49% p.a.
Profit Margin
13%
Future PE
22x
Share price in 2029
zł311.79